NS · Healthcare

Sandu Pharmaceuticals Ltd (524703)

Pharmaceuticals & Biotechnology

Sandu Pharmaceuticals Ltd (524703) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $391.30M, P/E ratio is 22.68, net margin is 2.3%, dividend yield is 1.98%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 524703

Market cap

$391.30M

P/E ratio

22.68

Net margin

2.3%

Dividend yield

1.98%

Sandu Pharmaceuticals Ltd (524703) — FAQ

What is Sandu Pharmaceuticals Ltd's market cap?

Sandu Pharmaceuticals Ltd (524703) has a reported market cap of $391.30M (data as of 2026-07-10).

What is 524703's P/E ratio?

The price-to-earnings (P/E) ratio for Sandu Pharmaceuticals Ltd (524703) is 22.68 (data as of 2026-07-10).

Does Sandu Pharmaceuticals Ltd pay a dividend?

Sandu Pharmaceuticals Ltd (524703) shows a reported dividend yield of 1.98%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Sandu Pharmaceuticals Ltd in?

Sandu Pharmaceuticals Ltd (524703) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 524703 listed on?

524703 is listed on NS.

What is Sandu Pharmaceuticals Ltd's net margin?

Sandu Pharmaceuticals Ltd (524703) reports a net margin of 2.3% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)